Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus

Biochem Biophys Res Commun. 1992 May 15;184(3):1152-7. doi: 10.1016/s0006-291x(05)80003-8.

Abstract

A Japanese child born to an HBeAg-positive carrier mother received anti-HBs immunoglobulins and a plasma-derived HBs vaccine with a poor anti-HBs-antibody response. The child, who is now 3 years old, is presently suffering from chronic hepatitis with unusual serological findings that are positive for HBsAg, anti-HBs and HBeAg, since being infected with a measles virus at 12 months of age. The nucleotide sequences of the S region of HBV DNA obtained from the patient, the mother and an HBeAg-positive brother were completely identical except for one nucleotide at position 587 (mother and brother: guanosine, patient: adenosine), giving an amino acid change: Gly - greater than Arg at position 145 of the major HBs protein.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Sequence
  • Arginine*
  • Base Sequence
  • Carrier State
  • DNA, Viral / genetics
  • DNA, Viral / isolation & purification
  • Female
  • Genetic Variation*
  • Glycine*
  • Hepatitis B / immunology*
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B Surface Antigens / genetics*
  • Hepatitis B Vaccines
  • Hepatitis B e Antigens / analysis
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology*
  • Humans
  • Immunization, Passive*
  • Infant, Newborn
  • Male
  • Molecular Sequence Data
  • Polymerase Chain Reaction / methods
  • Vaccines, Synthetic / administration & dosage
  • Viral Hepatitis Vaccines / administration & dosage

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines
  • Hepatitis B e Antigens
  • Vaccines, Synthetic
  • Viral Hepatitis Vaccines
  • Arginine
  • Glycine